Silverback Therapeutics Appoints Vickie L. Capps to Board of Directors and Audit Committee Chair

SEATTLE--(BUSINESS WIRE)--Silverback Therapeutics (“Silverback”), a biopharmaceutical company advancing a pipeline of therapies that are systemically delivered, but locally active, today announced the appointment of Vickie L. Capps as director and audit committee chair...
Login to comment.